•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A05444 Summary:

BILL NOA05444B
 
SAME ASNo Same As
 
SPONSORRosenthal
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L
 
Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.
Go to top

A05444 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5444--B
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                    February 14, 2025
                                       ___________
 
        Introduced  by  M.  of  A.  ROSENTHAL  --  read once and referred to the
          Committee on Insurance -- committee discharged, bill amended,  ordered
          reprinted  as  amended  and  recommitted  to  said  committee -- again
          reported from said committee with  amendments,  ordered  reprinted  as
          amended and recommitted to said committee

        AN ACT to amend the insurance law, in relation to coverage for perimeno-
          pausal and menopausal care and treatment
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
     2  amended by adding a new paragraph 41 to read as follows:
     3    (41) (A) Every policy that provides coverage for hospital, surgical or
     4  medical  care  shall  provide coverage for perimenopausal and menopausal
     5  care and treatment administered by a physician or other licensed  health
     6  care  provider.  Symptoms  of menstrual complications for perimenopausal
     7  and menopausal care authorized under this paragraph include, but are not
     8  limited to: irregular menstrual  periods,  temporary  cognitive  changes
     9  related  to  the menopause transition, hot flashes, chills, slowed meta-
    10  bolism, vaginal or bladder problems,  decrease  in  fertility,  loss  of
    11  bone,  increase in low-density lipoprotein cholesterol levels, and sleep
    12  disruption including night sweats.
    13    (B) For purposes of subparagraph (A) of this paragraph:
    14    (i) "Menopause" means the permanent cessation  of  ovulation  so  that
    15  ovaries  stop  releasing  follicles  and  stop  producing  estrogen  and
    16  progesterone. For women with an intact uterus, menopause is marked by  a
    17  twelve month absence  of menstruation.
    18    (ii)  "Perimenopause" means the transition period from the late repro-
    19  ductive phase to  the  permanent  cessation  of  ovarian  function  with
    20  absence of menstruation.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01048-07-5

        A. 5444--B                          2
 
     1    (C)  Such coverage required pursuant to subparagraph (A) of this para-
     2  graph shall not be subject to annual  deductibles,  co-payment  fees  or
     3  coinsurance.
     4    § 2. Subsection (k) of section 3221 of the insurance law is amended by
     5  adding a new paragraph 24 to read as follows:
     6    (24)(A)  Every policy that provides coverage for hospital, surgical or
     7  medical care shall provide coverage for  perimenopausal  and  menopausal
     8  care  or  treatment administered by a physician or other licensed health
     9  care provider. Symptoms of menstrual  complications  for  perimenopausal
    10  and menopausal care authorized under this paragraph include, but are not
    11  limited  to:  irregular  menstrual  periods, temporary cognitive changes
    12  related to the menopause transition, hot flashes, chills,  slowed  meta-
    13  bolism,  vaginal  or  bladder  problems,  decrease in fertility, loss of
    14  bone, increase in low-density lipoprotein cholesterol levels, and  sleep
    15  disruption including night sweats.
    16    (B) For purposes of subparagraph (A) of this paragraph:
    17    (i)  "Menopause"  means  the  permanent cessation of ovulation so that
    18  ovaries  stop  releasing  follicles  and  stop  producing  estrogen  and
    19  progesterone. For women with an intact uterus, menopasuse is marked by a
    20  twelve month absence  of menstruation.
    21    (ii)  "Perimenopause" means the transition period from the late repro-
    22  ductive phase to  the  permanent  cessation  of  ovarian  function  with
    23  absence of menstruation.
    24    (C)  Such coverage required pursuant to subparagraph (A) of this para-
    25  graph shall not be subject to annual  deductibles,  co-payment  fees  or
    26  coinsurance.
    27    §  3.  Section  4303  of  the insurance law is amended by adding a new
    28  subsection (ww) to read as follows:
    29    (ww)(1) Any contract issued by  a  medical  expense  indemnity  corpo-
    30  ration,  a hospital service corporation or a health services corporation
    31  that provides coverage for hospital,  surgical  or  medical  care  shall
    32  provide  coverage  for  perimenopausal  and menopausal care or treatment
    33  administered by a physician or  other  licensed  health  care  provider.
    34  Symptoms  of  menstrual  complications for perimenopausal and menopausal
    35  care authorized under this paragraph include, but are  not  limited  to:
    36  irregular  menstrual periods, temporary cognitive changes related to the
    37  menopause transition, hot flashes, chills, slowed metabolism, vaginal or
    38  bladder problems, decrease in fertility, loss of bone, increase in  low-
    39  density  lipoprotein  cholesterol levels, and sleep disruption including
    40  night sweats.
    41    (2) For purposes of paragraph one of this subsection:
    42    (A) "Menopause" means the permanent cessation  of  ovulation  so  that
    43  ovaries  stop  releasing  follicles  and  stop  producing  estrogen  and
    44  progesterone.   For women with an intact uterus, menopasuse is marked by
    45  a twelve month absence  of menstruation.
    46    (B) "Perimenopause" means the transition period from the  late  repro-
    47  ductive  phase  to  the  permanent  cessation  of  ovarian function with
    48  absence of menstruation.
    49    (3)  Such  coverage  required  pursuant  to  paragraph  one  of   this
    50  subsection  shall  not be subject to annual deductibles, co-payment fees
    51  or coinsurance.
    52    § 4. This act shall take effect on the first of January next  succeed-
    53  ing  the  date  on  which  it shall have become a law and shall apply to
    54  policies issued, reissued, renewed, modified or amended on or after such
    55  date.
Go to top